US EditionKairos Pharma Receives DoD Grant for Lung Cancer Biomarker Research
Summary by citybuzz.co
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Kairos Pharma Receives DoD Grant for Lung Cancer Biomarker Research
The U.S. Department of Defense has awarded a substantial $876,000 grant to Cedars-Sinai Medical Center to support critical biomarker research for Kairos Pharma’s innovative lung cancer treatment approach. The funding will support research conducted in Dr. Neil Bhowmick’s laboratory, targeting patients with EGFR-driven non-small cell lung cancer who are developing resistance to osimertinib. The research focuses on identifying potential biomarkers…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
